Hong Kong
# |
Name |
Capital Expenditure |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD -596.26 M
|
Dec. 31, 2023 | USD 17.19 | 2.12% |
|
Hong Kong |
|
2 |
USD -239.97 M
|
Dec. 31, 2023 | USD 0.38 | 2.08% |
|
Hong Kong |
|
3 |
USD -205.91 M
|
Dec. 31, 2023 | USD 1.48 | 0.68% |
|
Hong Kong |
|
4 |
USD -90.12 M
|
Dec. 31, 2023 | USD 0.41 | 0.30% |
|
Hong Kong |
|
5 |
USD -68.82 M
|
Dec. 31, 2023 | USD 0.25 | -2.07% |
|
Hong Kong |
|
6 |
USD -54.27 M
|
Dec. 31, 2023 | USD 0.80 | 2.57% |
|
Hong Kong |
|
7 |
USD -44.78 M
|
Dec. 31, 2023 | USD 0.93 | 2.39% |
|
Hong Kong |
|
8 |
USD -32.61 M
|
Dec. 31, 2023 | USD 2.68 | -1.44% |
|
Hong Kong |
|
9 |
USD -21.15 M
|
Dec. 31, 2023 | USD 0.22 | -1.18% |
|
Hong Kong |
|
10 |
USD -20.45 M
|
Dec. 31, 2023 | USD 0.16 | -3.21% |
|
Hong Kong |
|
11 |
USD -14.63 M
|
Dec. 31, 2023 | USD 0.13 | -0.02% |
|
Hong Kong |
|
12 |
USD -7.48 M
|
Dec. 31, 2023 | USD 0.44 | 1.16% |
|
Hong Kong |
|
13 |
USD -4.48 M
|
Dec. 31, 2023 | USD 0.19 | -0.02% |
|
Hong Kong |
|
14 |
USD -1.74 M
|
Dec. 31, 2023 | USD 0.37 | 4.31% |
|
Hong Kong |
|
15 |
USD -911.81 K
|
Dec. 31, 2023 | USD 5.25 | -2.96% |
|
Hong Kong |
|
16 |
USD -5.38 K
|
June 30, 2024 | USD 3.80 | 0.53% |
|
Hong Kong |
The Biotechnology company in Hong Kong with the highest Capital Expenditure is BeiGene, Ltd. (HKSE: 6160.HK) at USD -596.26 M.
The Biotechnology company in Hong Kong with the lowest Capital Expenditure is Regencell Bioscience Holdings Limited (NasdaqCM: RGC) at USD -5.38 K.
The top 10 Biotechnology companies in Hong Kong by Capital Expenditure are BeiGene, Ltd., Sino Biopharmaceutical Limited, The United Laboratories International Holdings Limited, SSY Group Limited, China Traditional Chinese Medicine Holdings Co. Limited, Guangdong Hybribio Biotech Co.,Ltd., China Medical System Holdings Limited, HUTCHMED (China) Limited, Frontage Holdings Corporation and Lee's Pharmaceutical Holdings Limited.
The bottom 10 Biotechnology companies in Hong Kong by Capital Expenditure are Regencell Bioscience Holdings Limited, Prenetics Global Limited, Sirnaomics Ltd., Jilin Province Huinan Changlong Bio-pharmacy Company Limited, OrbusNeich Medical Group Holdings Limited, SinoMab BioScience Limited, Lee's Pharmaceutical Holdings Limited, Frontage Holdings Corporation, HUTCHMED (China) Limited and China Medical System Holdings Limited.